Annexon, Inc.
Status: Publicly traded
Direct answer
Annexon, Inc. is publicly traded on NASDAQ under the ticker ANNX.
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway. The company targets this pathway to address specific disease mechanisms, such as those seen in...
Can you invest in Annexon, Inc.?
Yes. Annexon, Inc. is publicly traded on NASDAQ under the ticker ANNX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Annexon, Inc.
Detailed equity research is provided by MarketSnap.